1. Epithelial–mesenchymal transition and its transcription factors
   Pallabi Debnath et al, 2022, Bioscience Reports CrossRef
2. The deadly cross-talk between Hippo pathway and epithelial–mesenchymal transition (EMT) in cancer
   Ioanna Akrida et al, 2022, Molecular Biology Reports CrossRef
3. Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9
   Jiaxin Liang et al, 2023, Cancer Science CrossRef
4. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises
   Ángel Ortega et al, 2021, International Journal of Molecular Sciences CrossRef
5. Use of iTRAQ‐based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma
   Ko‐Chao Lee et al, 2023, Journal of Cellular and Molecular Medicine CrossRef
6. Subcellular localization of HMGB1 in human cholangiocarcinoma: correlation with tumor stage
   Nattawan Suwannakul et al, 2021, Discover Oncology CrossRef
7. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
   Chin-Yap Loh et al, 2019, Cells CrossRef
8. NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression
   Lijun Wang et al, 2021, Frontiers in Oncology CrossRef
9. Role of Muscarinic Acetylcholine Signaling in Gastrointestinal Cancers
   Mitsuru Konishi et al, 2019, Biomedicines CrossRef
10. MicroRNA-520f-3p inhibits proliferation of gastric cancer cells via targeting SOX9 and thereby inactivating Wnt signaling
    Jian-qing Chen et al, 2020, Scientific Reports CrossRef
11. Glycyrrhizin Attenuates Carcinogenesis by Inhibiting the Inflammatory Response in a Murine Model of Colorectal Cancer
    Guifeng Wang et al, 2021, International Journal of Molecular Sciences CrossRef